Intact Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26M Buy
202,100
+28,600
+16% +$3.35M 0.74% 31
2026
Q1
$20.9M Sell
173,500
-9,600
-5% -$1.11M 0.59% 41
2025
Q4
$19.3M Sell
183,100
-17,600
-9% -$1.65M 0.55% 48
2025
Q3
$16.8M Buy
200,700
+2,200
+1% +$181K 0.51% 52
2025
Q2
$15.7M Sell
198,500
-17,600
-8% -$1.4M 0.53% 50
2025
Q1
$19.4M Buy
216,100
+3,500
+2% +$327K 0.67% 41
2024
Q4
$21.1M Buy
212,600
+46,400
+28% +$4.78M 0.74% 33
2024
Q3
$18.9M Buy
166,200
+22,940
+16% +$2.73M 0.63% 38
2024
Q2
$17.7M Sell
143,260
-6,540
-4% -$842K 0.66% 35
2024
Q1
$19.8M Buy
149,800
+15,700
+12% +$1.94M 0.78% 31
2023
Q4
$14.6M Buy
134,100
+5,400
+4% +$561K 0.59% 34
2023
Q3
$13.2M Buy
128,700
+9,200
+8% +$992K 0.57% 43
2023
Q2
$13.8M Sell
119,500
-32,000
-21% -$3.63M 0.56% 43
2023
Q1
$16.1M Buy
151,500
+22,100
+17% +$2.39M 0.66% 35
2022
Q4
$14.4M Sell
129,400
-36,800
-22% -$3.76M 0.62% 37
2022
Q3
$14.3M Sell
166,200
-38,200
-19% -$3.41M 0.47% 46
2022
Q2
$18.7M Sell
204,400
-17,800
-8% -$1.58M 0.58% 36
2022
Q1
$18.2M Sell
222,200
-14,000
-6% -$1.1M 0.46% 49
2021
Q4
$18.1M Sell
236,200
-11,800
-5% -$940K 0.46% 49
2021
Q3
$18.6M Buy
248,000
+11,500
+5% +$875K 0.52% 41
2021
Q2
$18.4M Sell
236,500
-11,352
-5% -$844K 0.52% 41
2021
Q1
$18.2M Buy
247,852
+30,602
+14% +$2.26M 0.55% 39
2020
Q4
$17M Hold
217,250
0.55% 39
2020
Q3
$17.2M Sell
217,250
-4,821
-2% -$378K 0.59% 36
2020
Q2
$16.4M Buy
222,071
+22,532
+11% +$1.7M 0.61% 33
2020
Q1
$14.7M Buy
199,539
+20,541
+11% +$1.61M 0.64% 35
2019
Q4
$15.5M Buy
178,998
+11,318
+7% +$930K 0.53% 38
2019
Q3
$13.5M Buy
167,680
+2,725
+2% +$218K 0.48% 42
2019
Q2
$13.2M Sell
164,955
-3,563
-2% -$273K 0.47% 45
2019
Q1
$13.4M Sell
168,518
-103,857
-38% -$7.77M 0.48% 44
2018
Q4
$19.9M Hold
272,375
0.81% 28
2018
Q3
$18.4M Sell
272,375
-524
-0.2% -$33.4K 0.66% 34
2018
Q2
$15.8M Hold
272,899
0.57% 34
2018
Q1
$14.2M Buy
272,899
+267,659
+5,108% +$14.5M 0.55% 41
2017
Q4
$282K Hold
5,240
0.01% 194
2017
Q3
$320K Hold
5,240
0.01% 185
2017
Q2
$320K Hold
5,240
0.01% 216
2017
Q1
$318K Sell
5,240
-1,258
-19% -$76.3K 0.01% 218
2016
Q4
$365K Sell
6,498
-1,362
-17% -$79.7K 0.01% 219
2016
Q3
$468K Sell
7,860
-21,694
-73% -$1.27M 0.02% 204
2016
Q2
$1.63M Buy
29,554
+3,983
+16% +$212K 0.07% 129
2016
Q1
$1.29M Hold
25,571
0.05% 136
2015
Q4
$1.29M Hold
25,571
0.06% 136
2015
Q3
$1.2M Sell
25,571
-2,515
-9% -$134K 0.05% 134
2015
Q2
$1.52M Buy
28,086
+5,868
+26% +$329K 0.06% 126
2015
Q1
$1.22M Sell
22,218
-5,449
-20% -$309K 0.05% 132
2014
Q4
$1.5M Buy
27,667
+3,353
+14% +$187K 0.06% 123
2014
Q3
$1.38M Hold
24,314
0.06% 118
2014
Q2
$1.34M Hold
24,314
0.05% 94
2014
Q1
$1.32M Sell
24,314
-4,506
-16% -$233K 0.06% 99
2013
Q4
$1.38M Hold
28,820
0.07% 80
2013
Q3
$1.31M Buy
28,820
+18,445
+178% +$842K 0.07% 74
2013
Q2
$460K Buy
+10,375
New +$463K 0.02% 81

Other funds holding MRK

Intact Investment Management's MRK Position: Q2 2026 in Review

Intact Investment Management increased its Merck (MRK) stake by 16% in Q2 2026, buying an estimated $3.35M and bringing the position to 202,100 shares worth $26M. The position accounts for 0.74% of the portfolio, ranked #31.

Intact Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Intact Investment Management held 202,100 shares of Merck worth $26M as of Q2 2026.
  • Intact Investment Management bought 28,600 Merck shares in Q2 2026, an estimated $3.35M.
  • Merck made up 0.74% of Intact Investment Management's portfolio in Q2 2026, its #31 holding.
  • Intact Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.